Adial Pharmaceuticals Inc... (ADIL)
undefined
undefined%
At close: undefined
1.04
-4.58%
After-hours Jan 07, 2025, 05:09 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue 564.00 60.50K 55.11K 564.00 565.00 563.00 565.00 565.00 565.00
Gross Profit -564 -60.50K -55.11K -564 -565 -563 -565 -565 -565
Operating Income -6.89M -13.32M -19.29M -10.93M -8.24M -6.99M -995.29K -410.81K -819.26K
Interest Income 69.78K 63.34K 6.54K 32.49K 95.23K 7.39K 367.00 240.00 1.26K
Pretax Income -7.00M -12.73M -19.52M -10.89M -8.59M -11.63M -1.14M -420.20K -817.99K
Net Income -7.00M -12.73M -19.42M -10.86M -8.59M -11.63M -1.14M -420.20K -817.99K
Selling & General & Admin 5.62M 9.14M 9.34M 5.07M 4.28M 6.62M 813.18K 264.66K 497.15K
Research & Development 1.27M 4.18M 8.40M 5.85M 3.97M 368.46K 182.11K 146.14K 322.11K
Other Expenses n/a n/a 46.49K 2.50K n/a n/a n/a n/a n/a
Operating Expenses 6.89M 13.32M 17.74M 10.93M 8.24M 6.99M 995.29K 410.81K 819.26K
Interest Expense n/a n/a n/a n/a n/a 1.17M 144.54K 9.64K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 6.89M 13.32M 17.74M 10.93M 8.24M 6.99M 995.29K 410.81K 819.26K
Income Tax n/a -502 -94.08K -32.49K -76.06K -3.48M 367.00 9.64K 1.26K
Shares Outstanding (Basic) 1.42M 1.06M 743.55K 498.52K 394.10K 190.37K 218.99K 191.13K 191.28K
Shares Outstanding (Diluted) 1.42M 1.06M 743.55K 498.52K 394.10K 190.37K 218.99K 191.13K 191.28K
EPS (Basic) -5.44 -11.98 -26.12 -21.79 -21.8 -61.1 -5.2 -2.2 -4.28
EPS (Diluted) -5.44 -11.98 -26.12 -21.79 -21.8 -61.1 -5.2 -2.2 -4.28
EBITDA -7.00M -13.32M -19.46M -10.93M -8.15M -6.98M -994.35K -410.00K -817.43K
Depreciation & Amortization 564.00 564.00 55.11K 564.00 565.00 563.00 565.00 565.00 565.00